Archives

An estimated 50,000 people will die this year from colorectal cancer in the U.S.  In this article Dr. Adkisson and his patient Kimberly Dabbelt, a colon cancer survivor, discuss the disease and early detection. 

The American Cancer Society is now recommending Americans at average risk for colorectal cancer begin colorectal cancer screenings at age 45 rather than age 50. Through extensive analysis and research, the American Cancer Society has come to the conclusion that lowering the starting age for …

It’s hard to stomach the thought. But for the estimated 26,000 people who will be diagnosed with stomach cancer this year, it could be their only chance at survival.

Gastroenterology Associates and The Endoscopy Center would like to congratulate Fares S. Hakim, M.D. on his nomination for American College of Gastroenterology Governor of Northern Florida. It is an honor and a privilege to serve in this leadership position. Dr. Hakim, along with his partners …

Gastroenterology Associates of Pensacola achieved a 100% score for the Quality performance category through Three Facet Data Mining to identify custom codes and terminology used in their EHR and practice management system. 

At your annual physical, it’s standard for the doctor to check your weight, blood pressure, and heart rate. But if you were born between 1945 and 1965, you should consider asking your doctor for another test: one for hepatitis C.  

Clostridium difficile colitis results from disruption of normal healthy bacteria in the colon, often from antibiotics. C. difficile can also be transmitted from person to person by spores. It can cause severe damage to the colon and even be fatal.  

Advances in screening and treatment have significantly lowered the mortality rates of many cancers, but one type of cancer that remains markedly deadly is pancreatic cancer.  

Are PPIs Linked With Increased Dementia Risk? The Latest Evidence Says No  

Patients with breast cancer should not undergo CRC (colorectal cancer) screening at intervals different from the general population. In patients with breast cancer